Clinical Trial Market Research Reports & Industry Analysis
Clinical Trial Industry Research & Market Reports
-
Friedreich Ataxia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Friedreich Ataxia Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Thrombocytopenic Purpura) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Clinical trials scenario. ... Read More
-
Chronic Obstructive Pulmonary Disease (COPD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... more than 126 million diagnosed prevalent cases of COPD across 16 pharmaceutical markets. There are a good number of marketed innovator drugs for the treatment of COPD, mostly receptor agonists. Among the pipeline molecules for ... Read More
-
North America Clinical Trial Supply & Logistics Market Size, Share & Industry Trends Analysis Report By End-user, By Therapeutic Area, By Phase (Phase III, Phase II, Phase I and Phase IV), By Service, By Country and Growth Forecast, 2022 - 2028
... and Growth Forecast, 2022 - 2028 The North America Clinical Trial Supply & Logistics Market would witness market growth of 6.6% CAGR during the forecast period (2022-2028). The development of digital technology enabled the surmounting ... Read More
-
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Hereditary Angioedema (HAE) (C1 Esterase ... Read More
-
Keratoconjunctivitis Sicca (Dry Eye) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Keratoconjunctivitis Sicca (Dry Eye) Clinical trials scenario. This report provides top line data ... Read More
-
Neuroblastoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Neuroblastoma Clinical trials scenario. This report provides top line data relating to the clinical trials on Neuroblastoma. Report includes ... Read More
-
Glaucoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Glaucoma Clinical trials scenario. This report provides top line data relating to the clinical trials on Glaucoma. Report includes ... Read More
-
Multiple Sclerosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Multiple Sclerosis Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Mycosis Fungoides Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Mycosis Fungoides Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
Global Clinical Trial Supply & Logistics Market Size, Share & Industry Trends Analysis Report By End-user, By Therapeutic Area, By Phase (Phase III, Phase II, Phase I and Phase IV), By Service, By Regional Outlook and Forecast, 2022 - 2028
... and Forecast, 2022 - 2028 The Global Clinical Trial Supply & Logistics Market size is expected to reach $5.5 billion by 2028, rising at a market growth of 7.8% CAGR during the forecast period. Clinical ... Read More
-
Herpes Zoster (Shingles) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Herpes Zoster (Shingles) Clinical trials scenario. This report provides top line data relating to the ... Read More
-
B-Cell Non-Hodgkin Lymphoma (NHL) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... more than 1.7 million diagnosed prevalent cases of B-cell NHL across 16 pharmaceutical markets. There are a good number of marketed innovator drugs for the treatment of B-cell NHL, mostly protein/peptide inhibitors and receptor antagonists.. ... Read More
-
Psoriasis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Psoriasis Clinical trials scenario. This report provides top line data relating to the clinical trials on Psoriasis. Report includes ... Read More
-
eClinical Solutions Market by Product (CDMS, eCOA, CTMS, RTSM, ETMF, Analytics, Safety), Delivery (Web-hosted, Licensed Enterprise, Cloud-based), End User (Pharma, Hospitals, CROs), Clinical Trial Phases (Phase I, II) & Region - Global Forecasts to 2027
... The global eClinical Solutions market is projected to reach USD 17.9 billion in 2027 from USD 9.6 billion in 2022 at a CAGR of 13.3%. Rising operational costs and regulatory requirements pertaining to clinical research ... Read More
-
Global Blockchain Technology in Healthcare Market Size study & Forecast, by Network Type (Private, Public, Others), By Application (Clinical Data Exchange & Interoperability, Claims Adjudication & Billing, Supply Chain Management, Clinical Trials & eConsent, Others), By End-user (Providers, Payers, Biopharmaceutical & Medical Device Companies, Others) and Regional Analysis, 2022-2029
... By End-user (Providers, Payers, Biopharmaceutical & Medical Device Companies, Others) and Regional Analysis, 2022-2029 Global Blockchain Technology in Healthcare Market is valued at approximately USD 1.19 billion in 2021 and is anticipated to grow with ... Read More
-
Cell & Gene Therapy Manufacturing Services Market by Type (Allogeneic, Autologous, Viral Vector, Non-viral vector), Indication (Oncology, Orthopedic, Ophthalmology), Application (Clinical, Commercial), End User (Pharma, Biotech) - Global Forecast to 2027
... gene therapy manufacturing services market size is projected to reach USD 11.5 billion by 2027 from USD 5.1 billion in 2022, at a CAGR of 17.5% during the forecast period. Growth in this market can ... Read More
-
Global Clinical Trials Management System Market Size study & Forecast, by Solution Type (Enterprise, Site) by Delivery Mode (Web & Cloud-based, On-premise), by Component (Software, Services), by End-User (Pharmaceutical and Biotechnology Firms, Medical Device Firms, Others), and Regional Analysis, 2022-2029
... Others), and Regional Analysis, 2022-2029 Global Clinical Trials Management System Market is valued at approximately USD 1.50 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 13.9% over ... Read More
-
Acute Lymphocytic Leukemia (ALL) Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
... and 10-year patient-based forecast (PBF) across the eight major pharmaceutical markets (8MM) for marketed and pipeline therapies with established mechanisms of action and cell therapies by class, including early to late- clinical stage pipeline products, ... Read More
-
Chronic Lymphocytic Leukemia (CLL) Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
... and 10-year patient-based forecast (PBF) across the eight major pharmaceutical markets (8MM) for marketed and pipeline therapies with established mechanisms of action and cell therapies by class, including early to late- clinical stage pipeline products, ... Read More
-
Global Clinical Trial Imaging Market 2023-2029
... costs. In particular, using time-to-progression (often detected by imaging) rather than survival as the outcome measure can reduce costs and improve timeliness. Gen Consulting Company predicts the global clinical trial imaging market will grow from ... Read More
-
Multiple Myeloma Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
... patient-based forecast (PBF) across the eight major markets (8MM) for marketed and pipeline therapies with established mechanisms of action and cell therapies by class, including early to late clinical stage pipeline products, with a launch ... Read More
-
Clinical Trial Management Systems Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... COVID-19 pandemic affected the clinical research activities as a large number of clinical studies on other diseases around the world were disrupted by the pandemic and the companies shifted their focus to the development of ... Read More
-
Europe Clinical Trials Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... and the increasing prevalence of diseases. Key Highlights Another driving factor is the increasing focus on rare diseases and multiple orphan drugs in the pipeline. As rare diseases have considerably low prevalence rate, as compared ... Read More
-
Neurology Clinical Trials Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... unprecedented event that has impacted nearly every healthcare business around the world. The COVID-19 disease affects older people as well as people with underlying comorbidities. Neurological diseases are a common cause of mortality rate in ... Read More
Research Assistance
